Literature DB >> 6409929

Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.

T F Tse, W E Clutter, S D Shah, J P Miller, P E Cryer.   

Abstract

The mechanisms of postprandial glucose counterregulation-those that blunt late decrements in plasma glucose, prevent hypoglycemia, and restore euglycemia-have not been fully defined. To begin to clarify these mechanisms, we measured neuroendocrine and metabolic responses to the ingestion of glucose (75 g), xylose (62.5 g), mannitol (20 g), and water in ten normal human subjects to determine for each response the magnitude, temporal relationships, and specificity for glucose ingestion. Measurements were made at 10-min intervals over 5 h. By multivariate analysis of variance, the plasma glucose (P < 0.0001), insulin (P < 0.0001), glucagon (P < 0.03), epinephrine (P < 0.0004), and growth hormone (P < 0.01) curves, as well as the blood lactate (P < 0.0001), glycerol (P < 0.001), and beta-hydroxybutyrate (P < 0.0001) curves following glucose ingestion differed significantly from those following water ingestion. However, the growth hormone curves did not differ after correction for differences at base line. In contrast, the plasma norepinephrine (P < 0.31) and cortisol (P < 0.24) curves were similar after ingestion of all four test solutions, although early and sustained increments in norepinephrine occurred after all four test solutions. Thus, among the potentially important glucose regulatory factors, only transient increments in insulin, transient decrements in glucagon, and late increments in epinephrine are specific for glucose ingestion. They do not follow ingestion of water, xylose, or mannitol. Following glucose ingestion, plasma glucose rose to peak levels of 156+/-6 mg/dl at 46+/-4 min, returned to base line at 177+/-4 min, reached nadirs of 63+/-3 mg/dl at 232+/-12 min, and rose to levels comparable to base line at 305 min, which was the final sampling point. Plasma insulin rose to peak levels of 150+/-17 muU/ml (P < 0.001) at 67+/-8 min. At the time glucose returned to base line, insulin levels (49+/-12 muU/ml) remained fourfold higher than base line (P < 0.01); thereafter they declined but never fell below base line. Plasma glucagon decreased from 95+/-14 pg/ml to nadirs of 67+/-11 pg/ml (P < 0.001) at 84+/-9 min and then rose progressively to peak levels of 114+/-17 pg/ml (P < 0.001 vs. nadirs) at 265+/-12 min. Plasma epinephrine, which was 18+/-4 pg/ml at base line, did not change initially and then rose to peak levels of 119+/-20 pg/ml (P < 0.001) at 271+/-13 min. These data indicate that the glucose counterregulatory process late after glucose ingestion is not solely due to the dissipation of insulin and that sympathetic neural norepinephrine, growth hormone, and cortisol do not play critical roles. They are consistent with, but do not establish, physiologic roles for the counterregulatory hormones-glucagon, epinephrine, or both-in that process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409929      PMCID: PMC1129182          DOI: 10.1172/jci110966

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Diminished insulin response to hyperglycemia in prediabetes and diabetes.

Authors:  J A Colwell; A Lein
Journal:  Diabetes       Date:  1967-08       Impact factor: 9.461

2.  Forearm glucose uptake during the oral glucose tolerance test in normal subjects.

Authors:  R A Jackson; N Peters; U Advani; G Perry; J Rogers; W H Brough; T R Pilkington
Journal:  Diabetes       Date:  1973-06       Impact factor: 9.461

3.  Plasma cortisol determination: radioimmunoassay and competitive protein binding compared.

Authors:  R W Farmer; C E Pierce
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

4.  Insulin secretion in diabetes mellitus.

Authors:  D M Kipnis
Journal:  Ann Intern Med       Date:  1968-11       Impact factor: 25.391

5.  Is there a delay in the plasma insulin response of patients with chemical diabetes mellitus?

Authors:  G M Reaven; S W Shen; A Silvers; J W Farquhar
Journal:  Diabetes       Date:  1971-06       Impact factor: 9.461

Review 6.  Glucagon physiology and pathophysiology.

Authors:  R H Unger
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

7.  Enzymic assay of glycerol, dihydroxyacetone, and glyceraldehyde.

Authors:  J K Pinter; J A Hayashi; J A Watson
Journal:  Arch Biochem Biophys       Date:  1967-08       Impact factor: 4.013

8.  Hormone-fuel interrelationships during fasting.

Authors:  G F Cahill; M G Herrera; A P Morgan; J S Soeldner; J Steinke; P L Levy; G A Reichard; D M Kipnis
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

9.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.

Authors:  H S Seltzer; E W Allen; A L Herron; M T Brennan
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

10.  A model of the kinetics of insulin in man.

Authors:  R S Sherwin; K J Kramer; J D Tobin; P A Insel; J E Liljenquist; M Berman; R Andres
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more
  14 in total

1.  Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings.

Authors:  C Berne; J Fagius; F Niklasson
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

2.  Haemodynamic and hormonal effects of two different oral glucose loads in normal human subjects.

Authors:  S Puvi-Rajasingham; B Wijeyekoon; P Natarajan; L P Watson; C J Mathias
Journal:  Clin Auton Res       Date:  1997-06       Impact factor: 4.435

3.  Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.

Authors:  N S Schwartz; W E Clutter; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

4.  Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.

Authors:  S Dinneen; A Alzaid; D Turk; R Rizza
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

5.  Effect of glucose and fat feeding on norepinephrine turnover in rats.

Authors:  S Welle; J Feldman
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

6.  Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man.

Authors:  S G Rosen; W E Clutter; M A Berk; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

7.  Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponectin and tumor necrosis factor alpha.

Authors:  A Avogaro; M Sambataro; A Marangoni; A Pianta; R Vettor; C Pagano; M C Marescotti; A Tiengo; G Beltramello
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

8.  Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.

Authors:  D R Hoelzer; G P Dalsky; W E Clutter; S D Shah; J O Holloszy; P E Cryer
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

9.  Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.

Authors:  G Bolli; P De Feo; G Perriello; S De Cosmo; P Compagnucci; F Santeusanio; P Brunetti; R H Unger
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

10.  Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion.

Authors:  T F Tse; W E Clutter; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.